|
|
Issue Date: February 3, 2022 |
|
ANNOUNCEMENTS
We received a very positive response when we featured some smaller companies early in January, so we decided to revisit the idea. This time we are covering MedTech Device Companies with patented, unique implant technology not yet available to the mainstream market. It will be fun to watch these companies expand their technology and eventually be brought to market or acquired by a larger entity looking to make a splash.
|
|
As always, thanks for reading, we are extremely grateful for our FANs.
|
|
This week we have:
- Golden Sawbone of the Week - Social Media Edition
- Little Guys, Big Ideas - Part II
- Osteocentreic
- Biorez
- Activortho
- 206Ortho
- PodiatryMeetings.com Calendar of Events
|
|
GOLDEN SAWBONE OF THE WEEK
Social Media Edition
|
|
Kamran Hamid, MD is a foot and ankle surgeon banging out ortho related industry humor.
This week @thisiskomron produced “REP MATH” which earned him our first ever Social Media GSA winner.
Congrats KomRon, I think this means you have officially made it.
|
|
|
|
Follow Us on LinkedIn!
https://www.linkedin.com/company/footandanklenews/
|
|
LITTLE GUYS, BIG IDEAS - PART II |
|
OSTEOCENTRIC
Ever thought about reinventing the wheel, OSTEOCENTRIC has a patented Unifi MI screw thread technology that could potentially disrupt all of orthopedics. It all has to do with mechanical versus standard buttress screw interface.
|
|
According to OSTEOCENTRIC, “UnifiMI mechanically integrates with bone to provide instant and lasting multi-axial stability and load sharing in normal, compromised and osteoporotic bone."
|
|
This video is worth watching and gives a visual representation of the technology, it is less than 2 minutes long. |
|
|
Look, screw thread technology is not as sexy as a newly launched Nitinol TAR Implant with Smart Poly-Wear Technology implanted with Robotic Surgical Assistance. Osteocentric has a few simple implant systems they have acquired, developed, or are currently developing. They can be found here. Osteocentric’s main asset (screw thread technology) is most likely a licensing play for the company if they can find the right partner or partners.
The issue I assume they are facing, is whether or not this technology is worth it for a massive player in Ortho? Even if it is game changing in terms of fixation is a company like DePuy Synthes going to scrap millions in inventory for a new screw thread, when the old one has done the job? What is the incremental gain in both function and revenue by doing an ankle fracture with this screw versus the old one? Orthocentric will probably need a couple less established newcomers or do it themselves to make this work long term. Amazing technology and will be something to watch as time goes on. Predicting big things for these guys.
|
|
BIOREZ
BIOREZ based out of New Haven, Connecticut has created a biocomposite soft tissue scaffold that is 510K FDA approved, intended for use in reinforcement of soft tissues that are repaired using suture or suture anchors during tendon repair surgery.
|
|
BioBrace is highly differentiated.
Unlike traditional implant materials that are either synthetic or biologic, BioBrace is a biocomposite of both. The proprietary biocomposite architecture features a highly porous type 1 collagen matrix (20 μm average pore size) reinforced with bioresorbable PLLA microfilaments (15 μm diameter), which are stylized green in the cross-section SEM image below. Biorez has category-defining innovation, with 20 granted patents and 10 pending.
|
|
Innovative solution for tendon and ligament healing.
The BioBrace reinforces, regenerates, and then resorbs. Its biomechanical profile enables load-sharing to reinforce ligament and tendon repair throughout the healing process, while its biologic matrix acts as a scaffold to support tissue regeneration. The BioBrace provides supplemental strength for approximately 2 years before naturally resorbing.
|
|
BIOREZ is a unique patented platform that could change the game in sports medicine and has a much more straight-line path to exit than Osteocentric. No need for harvesting or relying on a tissue bank for your procedures. A company that can offer a biocomposite ligament with their own implant system that is as reliable or stronger than allograft is big business. There are a ton of directions that Biorez can go in the future, excited to see where they end up and what products come out of this technology. |
|
ACTIVORTHO
Every Extremity company has a nitinol staple, some companies have multiple with various iterations: wide bridge, off-set legs, four legs…we get it! Nothing new. Why doesn’t anyone have any plates or screws made from Nitinol?
|
|
Because if it were that easy, everyone would have them already. Attempts have been made. It was rumored that BME was on track to launch a plate set prior to getting sold to J&J, but BME’s innovation quickly halted. |
|
MX Ortho (acquired by Arthrex in 2016) developed a screw with 510k approval and was listed as a predicate device for this screw, but that also never made it to market.
Up to this point many have tried, but no one has proved they can execute beyond a nail (DYNANAIL - which is badass) or staple (now a me-too product).
The continuous compression screw incorporates a helical expansion section in the smooth shaft of the screw which elongates as the distal thread engages bone to produce a continuous compression force across the fracture site.
Unlike the current industry standard screws, compression from the ActivOrtho technology is designed to be maintained up to 2mm as bones adjust.
If this screw can perform as advertised, the market for this screw is endless and the price tag for the technology will cost someone some serious coin.
|
|
206ORTHO
This is our first, pre-510k approval company we have featured.
206Ortho is an early-stage company that has developed and patented a unique bioresorbable, high strength material to repair broken bones. This company is still in the fundraising phase as it moves towards its path to market approval. They have completed 3 pre-clinical trials and have 13 granted patents with 50 applications still pending.
206 Ortho has developed and patented a fiber reinforced composite for load-
bearing implants that is safe, strong, tough and degradable for trauma to sports medicine applications. It is 206 Ortho’s unique capability to fine-tune the
degradation rate and mechanical properties, which allows it to customize implants for load-bearing applications, improving tissue ingrowth and avoiding removal.
Their technology fits with the direction of the market, and they are banking on innovation through new material. According to 206Ortho, their proprietary implant material technology is different due to the mechanical make up and potentially improved strength characteristics of those metallic alternatives currently available on the market today (OSSIO).
Ortho206 is actively seeking investment for those looking to jump in on an early stage MedTech Company. FAN is not an investor or have any other business relationships with the company. If you have any interest in potentially participating or want further information, you can click below, and we will make sure someone from the 206Ortho team contacts you directly.
(all you have to do is click - no forms )
|
|
PodiatryMeetings.com Calendar
Looking for a meeting?
This resource has an extensive amount of information for meeting opportunities where you can earn your required continuing education credits.
Click below to access the extensive meeting calendar.
|
|
AOFAS Upcoming Meetings & Courses |
|
|
February 10, 2022
20:00 - 21:00 GMT OR 8:00 - 9:00 pm CST
|
|
February 17-20, 2022
Phoenix, Arizona
|
|
September 14-17, 2022
Québec City, Canada
|
|
Share this Newsletter with Your Colleagues! |
|
Forward to a friend or use the social shares below. They can also use the button provided to sign up to receive newsletters just like you! |
|
About Foot and Ankle News & Contact Information
Foot and Ankle News is curated roundup of the most impactful news for Foot and Ankle Doctors, Rep’s, and Exec’s delivered weekly directly to your inbox.
- Breaking News
- Device Technology
- Journal Reviews
- Upcoming Events
- Practice Advice
All of our posts from our weekly email newsletter can be found at www.footandanklenews.com. Our newsletter goes out to over 12,000 foot and ankle surgeons and industry professionals across the country. The articles are created by a group of volunteers and freelance industry insiders. If you you would like to contact us or have an article or topic you would like to share, please submit it to: footandanklenews@gmail.com
|
|
|
|
|
|
|
